重大事件
即時報告
8-K
2026-06-11
Aura Biosciences就股東投票事項提交8-K即時報告
AI 繁中摘要
Aura Biosciences, Inc. 於2026年6月11日提交了一份8-K即時報告，內容涵蓋Item 5.07「股東投票事項」。報告顯示公司當日舉行了股東大會，並就若干事項進行表決，惟文件內未有披露具體投票結果或議案細節。投資者需查閱完整申報文件以了解實際投票情況。是次申報屬例行程序，對公司短期營運未見直接影響。
展開英文正文
EDGAR Filing Documents for 0001193125-26-267676 SEC.gov EDGAR Latest Filings Filings search tools Filing Detail SEC Home » Company Search » Current Page Form 8-K - Current report: SEC Accession No. 0001193125-26-267676 Filing Date 2026-06-11 Accepted 2026-06-11 16:31:01 Documents 9 Period of Report 2026-06-11 Items Item 5.07: Submission of Matters to a Vote of Security Holders Interactive Data Document Format Files Seq Description Document Type Size 1 8-K aura-20260611.htm iXBRL 8-K 67673 Complete submission text file 0001193125-26-267676.txt 179657 Data Files Seq Description Document Type Size 2 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT aura-20260611.xsd EX-101.SCH 27223 12 EXTRACTED XBRL INSTANCE DOCUMENT aura-20260611_htm.xml XML 4925 Mailing Address 80 GUEST STREET BOSTON MA 02135 Business Address 80 GUEST STREET BOSTON MA 02135 (617)500-8864 Aura Biosciences, Inc. (Filer) CIK: 0001501796 (see all company filings) EIN.: 320271970 | State of Incorp.: DE | Fiscal Year End: 1231 Type: 8-K | Act: 34 | File No.: 001-40971 | Film No.: 261083566 SIC: 2836 Biological Products, (No Diagnostic Substances) (CF Office: 03 Life Sciences)